InsideTracker, founded in 2009, is a pioneering company in the analytics and biotechnology sectors, leveraging its expertise to revolutionize healthcare and wellness solutions. Headquartered in the United States, InsideTracker operates at the intersection of Analytics, Biotechnology, Health Care, Health and Wellness, and Sports, offering a personalized health journey that optimizes longevity and vitality.
With its slogan, "Live healthier longer with a personalized Action Plan, combining data from blood biomarkers, DNA, and wearables," InsideTracker employs advanced technologies to deliver a health and wellness guide tailored to individual needs. By utilizing A.I. and extensive scientific research, the platform generates bespoke recommendations grounded in over ten billion biomarker data points.
In its most recent funding round, InsideTracker secured a $15.00M Series B investment on 08 September 2022, backed by investors including OurCrowd, Cornucopian Capital, PeakBridge, and BASF Venture Capital, underscoring its growth potential and innovation in personalized healthcare.